Quan Li

US Patent:

20210263045, Aug 26, 2021

Filed:

Apr 8, 2019

Appl. No.:

17/045482

Inventors:

- Austin TX, US
David E. GERBER - Dallas TX, US
Quan LI - Dallas TX, US
Shaheen KHAN - Dallas TX, US
Saad KHAN - Dallas TX, US
Yang XIE - Dallas TX, US
Jason Y. Park - Dallas TX, US
Farjana FATTAH - Dallas TX, US
Xin LUO - Dallas TX, US

Assignee:

The Board of Regents of the University of Texas System - Austin TX

International Classification:

G01N 33/68
G01N 33/564
C07K 16/28

Abstract:

The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy—induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.

US Patent:

20200366956, Nov 19, 2020

Filed:

Aug 4, 2020

Appl. No.:

16/984733

Inventors:

- Atlanta GA, US
Gregory Cooke - Woodstock GA, US
Alan Collins - Hixson TN, US
Quan Li - Alpharetta GA, US

Assignee:

AT&T Intellectual Property I, L.P. - Atlanta GA

International Classification:

H04N 21/433
H04N 21/458
H04N 21/435
H04N 21/442

Abstract:

Aspects of the subject disclosure may include, for example, identifying a media program and receiving a digital media stream including metadata and payload data, wherein the payload data includes program content of the identified media program. The metadata further includes program event information and program status information related to the identified media program. A recording status of the identified media program is determined, wherein an active recording status indicates the identified media program is being recorded at a media recorder. Responsive to the active recording status, an end of program is determined according to the identified media program, the program event information and the program status information. Responsive to the end of program, termination of the recording of the media program is initiated. Other embodiments are disclosed.

US Patent:

20200284803, Sep 10, 2020

Filed:

Feb 19, 2018

Appl. No.:

16/487335

Inventors:

- Austin TX, US
Edward WAKELAND - Dallas TX, US
Quan LI - Dallas TX, US
Saad KHAN - Dallas TX, US
Jason Y. PARK - Dallas TX, US
Xin LUO - Dallas TX, US
Yang XIE - Dallas TX, US

Assignee:

The Board of Regents of the University of Texas System - Austin TX

International Classification:

G01N 33/68
C07K 16/28

Abstract:

The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.

US Patent:

20200007927, Jan 2, 2020

Filed:

Jun 28, 2018

Appl. No.:

16/022198

Inventors:

- Atlanta GA, US
Gregory Cooke - Woodstock GA, US
Alan Collins - Hixson TN, US
Quan Li - Alpharetta GA, US

Assignee:

AT&T Intellectual Property I, L.P. - Atlanta GA

International Classification:

H04N 21/433
H04N 21/442
H04N 21/435
H04N 21/458

Abstract:

Aspects of the subject disclosure may include, for example, identifying a media program and receiving a digital media stream including metadata and payload data, wherein the payload data includes program content of the identified media program. The metadata further includes program event information and program status information related to the identified media program. A recording status of the identified media program is determined, wherein an active recording status indicates the identified media program is being recorded at a media recorder. Responsive to the active recording status, an end of program is determined according to the identified media program, the program event information and the program status information. Responsive to the end of program, termination of the recording of the media program is initiated. Other embodiments are disclosed.